CS 518

Known as: CS-518 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1991-2000
024619912000

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
Thromboxane A2 (TXA2) causes bronchoconstriction and bronchial hyperresponsiveness. Two types of TXA2 modifiers, one synthase… (More)
Is this relevant?
2000
2000
Beta-adrenoreceptor antagonists, such as propranolol, can provoke severe bronchoconstriction in asthmatic subjects. Recently we… (More)
Is this relevant?
1996
1996
The effects of CS-518, a thromboxane A2 synthase inhibitor, on antigen-induced dual bronchial responses, airway… (More)
Is this relevant?
1995
1995
We investigated whether or not acetylcholine elicited an endothelium-dependent contraction and whether an arachidonic acid… (More)
Is this relevant?
1994
1994
The aim of the study was to investigate if antigen-induced contraction of guinea pig lung parenchyma (GPLP) was an appropriate… (More)
Is this relevant?
1993
1993
The effects of CS-518 (sodium 2-(1-imidazolylmethyl)-4,5-dihydrobenzo [b]thiophene-6-carboxylate), a thromboxane A2 synthase… (More)
Is this relevant?
1993
1993
The anti-asthmatic effects of CS-518 (sodium 2-(1-imidazolylmethyl)-4,5-dihydrobenzo[b]thiophene-6-carboxylate) , a specific… (More)
Is this relevant?
1993
1993
The effects of CS-518 (sodium 2-(1-imidazolylmethyl)-4,5-dihydrobenzo[b]thiophene-6-carboxylate) , a thromboxane A2 synthase… (More)
Is this relevant?
1993
1993
When 50 mg CS-518, a novel thromboxane (TX) A2 synthase inhibitor, was orally administered to healthy male volunteers, the plasma… (More)
  • figure 1
Is this relevant?
1992
1992
A competitive enzyme-linked immunosorbent assay (ELISA) was developed for determination of CS-518, a novel thromboxane synthetase… (More)
Is this relevant?